Gapping up
In reaction to strong earnings/guidance: NLST +24.6%, KORS +18.7%, WSTL +7.7%, IPHI +6.4% (light volume), KFX +6% (thinly traded), ITUB +5.7%, POWI +5.6%, UBS +5.6%, IDTI +5.2%, (light volume), JCP +4.6%, (reported comparable store sales for Nov/Dec +3.1% and Q4 +2%), YUM +4.3%, LIOX +3.8%, HOLX +3.1%, RTEC +3%, AEIS +2.8%, HIG +2.4%, UNIS +1.4%, NUS+0.9%, APC +0.5% ( also provides Tronox-Related Contingent Liability update), .
M&A news: ATMI +26.1% and ENTG +4.6% ( Entegris to Acquire ATMI for $34/share in cash; ENTG sees deal immediately accretive), S +1.9% (Regulators uncertain of passing any potential merger of Sprint and T-moblie, according to reports).
Other news: FURX +76.2% (announces positive top-line results of two pivotal Phase III clinical trials of eluxadoline in patients with IBS-d; studies meet FDA and EMA primary endpoints), NURO +8.7% (announces broad SENSUS Distribution Agreement with DJO Global), DXCM +5.7% (FDA approves pediatric use of Dexcom's G4 platinum continuous monitoring system), AEZS +4.1% (Article on Phase 2 Results for Zoptarelin Doxorubicin in endometrial cancer published; Data showed that zoptarelin doxorubicin has clinically meaningful activity with low toxicity in women with advanced or recurrent LHRH receptor positive endometrial cancer), GILT +3.7% (Gilat Satellite disclosed notice received from FIMI - will purchase from York additional 2,106,121 ordinary shares of Gilat at a price of $5 per share), ACT +3.1% (still checking), MBT +3% ( raises dividend guidance and affirms growth in core markets at 2014 investor day), FTR +2.9% ( begins Regulatory Approval Process to Acquire AT&T Wireline, Broadband and Video Operations in Connecticut), ALU +2.9% and NOK +0.9% (still checking for anything specific), TTM +2.8% (following auto sales reported by several companies yesterday), LL +2.6% ( S.A.C. Capital discloses 5.0% passive stake in 13G filing ), GOGO +2.4% (still checking), TWTR +1.8% (still checking), BWLD +1.3% (following YUM results), ILMN +0.7% (disclosed its Board of Directors authorized up to $250.0 mln to repurchase shares), WEN +0.5% ( favorable comments on Mad Money), GOOG +0.4% ( S&P Dow Jones Indicies announces treatment of Google stock split in the S&P 100 and S&P 500), AAPL +0.4% (is ramping up its internet infrastructure network, according to reports ), WFM +0.2% and SWY +0.1% (Whole Foods confirms it Acquired Seven Dominick's Leases from Safeway)
Analyst comments: ZNGA +5.6% (upgraded to Buy from Neutral at UBS), ANGI +2.9% (upgraded to Outperform from Mkt Perform at Barrington Research), OPEN +2.8% (upgraded to Neutral from Sell at Citigroup), RMBS +1.6% (added to Focus List at Citigroup), GPS +1.2% (upgraded to Buy from Neutral at UBS), GILD +1.2% (upgraded to Outperform at Robert W. Baird; tgt raised to $103 on overwhelmingly positive Rx trends ), PFE +1% (upgraded to Buy from Hold at Jefferies), CVX +0.8% (upgraded to Strong Buy from Outperform at Raymond James), MRK +0.3% (Merck upgraded to Buy from Neutral at SunTrust)
M&A news: ATMI +26.1% and ENTG +4.6% ( Entegris to Acquire ATMI for $34/share in cash; ENTG sees deal immediately accretive), S +1.9% (Regulators uncertain of passing any potential merger of Sprint and T-moblie, according to reports).
Other news: FURX +76.2% (announces positive top-line results of two pivotal Phase III clinical trials of eluxadoline in patients with IBS-d; studies meet FDA and EMA primary endpoints), NURO +8.7% (announces broad SENSUS Distribution Agreement with DJO Global), DXCM +5.7% (FDA approves pediatric use of Dexcom's G4 platinum continuous monitoring system), AEZS +4.1% (Article on Phase 2 Results for Zoptarelin Doxorubicin in endometrial cancer published; Data showed that zoptarelin doxorubicin has clinically meaningful activity with low toxicity in women with advanced or recurrent LHRH receptor positive endometrial cancer), GILT +3.7% (Gilat Satellite disclosed notice received from FIMI - will purchase from York additional 2,106,121 ordinary shares of Gilat at a price of $5 per share), ACT +3.1% (still checking), MBT +3% ( raises dividend guidance and affirms growth in core markets at 2014 investor day), FTR +2.9% ( begins Regulatory Approval Process to Acquire AT&T Wireline, Broadband and Video Operations in Connecticut), ALU +2.9% and NOK +0.9% (still checking for anything specific), TTM +2.8% (following auto sales reported by several companies yesterday), LL +2.6% ( S.A.C. Capital discloses 5.0% passive stake in 13G filing ), GOGO +2.4% (still checking), TWTR +1.8% (still checking), BWLD +1.3% (following YUM results), ILMN +0.7% (disclosed its Board of Directors authorized up to $250.0 mln to repurchase shares), WEN +0.5% ( favorable comments on Mad Money), GOOG +0.4% ( S&P Dow Jones Indicies announces treatment of Google stock split in the S&P 100 and S&P 500), AAPL +0.4% (is ramping up its internet infrastructure network, according to reports ), WFM +0.2% and SWY +0.1% (Whole Foods confirms it Acquired Seven Dominick's Leases from Safeway)
Analyst comments: ZNGA +5.6% (upgraded to Buy from Neutral at UBS), ANGI +2.9% (upgraded to Outperform from Mkt Perform at Barrington Research), OPEN +2.8% (upgraded to Neutral from Sell at Citigroup), RMBS +1.6% (added to Focus List at Citigroup), GPS +1.2% (upgraded to Buy from Neutral at UBS), GILD +1.2% (upgraded to Outperform at Robert W. Baird; tgt raised to $103 on overwhelmingly positive Rx trends ), PFE +1% (upgraded to Buy from Hold at Jefferies), CVX +0.8% (upgraded to Strong Buy from Outperform at Raymond James), MRK +0.3% (Merck upgraded to Buy from Neutral at SunTrust)